Dr Osman Tribute
Abstract Submissions
Covid 19 Statement

Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 23.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 23.75 Contact Hours.

Surgical MOC Points
This activity provides up to 12.25 Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit http://www.absurgery.org

Mini Symposium: Earn up to 5.5 AMA PRA Category 1 Credits™ (5.5 Contact Hours)
Day 2: Earn up to 7.5 AMA PRA Category 1 Credits™ (7.5 Contact Hours)
Day 3: Earn up to 6.75 AMA PRA Category 1 Credits™ (6.75 Contact Hours)
Day 4: Earn up to 4.0 AMA PRA Category 1 Credits™ (4.0 Contact Hours)

Acknowledgment of Commercial Support

This activity is supported by educational grants from Acelity, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eisai Inc., Gilead Sciences, Hologic Inc., Immunomedics, KCI USA, Inc, Lilly, Novartis Pharmaceuticals Corporation, Puma Biotechnology, Inc.; and Seattle Genetics, Inc.

38th Annual Miami Breast Cancer Conference®

38th Annual Miami Breast Cancer Conference®

Virtual, Interactive Conference

March 4-7, 2021

Eastern Time

38th Annual Miami Breast Cancer Conference® Overview

Breast cancer represents a complicated family of diseases for which detection, diagnosis, and multimodal management strategies are continually evolving. With each lesson learned about the biology of these diseases, and with each improvement to the standards of care, new questions, challenges, and controversies arise. Therefore, practice-focused education that enables you to integrate the highest-quality methodologies into your clinic is essential. For 37 years, the multidisciplinary Miami Breast Cancer Conference® has met this educational need—bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists—to improve the care for patients with breast cancer.

In March 2021, the 38th Annual Miami Breast Cancer Conference® will continue this tradition and use innovative virtual technology to deliver the robust educational programming and top-notch presentations for which this conference is known. New in 2021, we have expanded our afternoon programming with additional tracks on pathology, radiation oncology, and nursing. To accommodate our international learners in non-US time zones, an international track will also be offered. Additionally, this year’s virtual program will feature world-class tumor board panels, multidisciplinary meet-the-expert sessions, poster talks, lively debates, and much, much more. Included among the many important clinical and practical topics on the agenda are contemporary management issues, oncology care in the COVID-19 era, practical application of genomics information, and patient-centered care. Register today to join us at the 38th Annual Miami Breast Cancer Conference®.

Hear it on Friday, use it on Monday

Acknowledgment of Commercial Support

This activity is supported by educational grants from Acelity, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eisai Inc., Gilead Sciences, Hologic Inc., Immunomedics, KCI USA, Inc, Lilly, Novartis Pharmaceuticals Corporation, Puma Biotechnology, Inc., and Seattle Genetics, Inc.

Target Audience

This educational program is intended for medical, surgical, and radiation oncologists; pathologists; and nurses/nurse practitioners interested in the treatment of patients with breast cancer. Fellows, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Integrate validated biomarkers, multi-gene assays, and tumor subtype information, as appropriate, to inform clinical decision-making and personalize therapy for patients with breast cancer
  • Utilize multidisciplinary treatment planning to incorporate evidence-based surgical, radiation, and systemic therapeutic approaches when appropriate to ensure optimal outcomes for patients with non-metastatic breast cancer
  • Incorporate high-level evidence from clinical trials of systemic therapies, along with expert guidance, into treatment planning in order to provide individualized care and optimized outcomes for patients with breast cancer
  • Describe ongoing clinical trials evaluating investigational agents and strategies that may offer additional treatment options for patients with breast cancer
  • Coordinate a multidisciplinary team-based approach to prevent, mitigate, and manage treatment-related adverse events for patients undergoing treatment for breast cancer to reduce risk of harm while maintaining efficacy

Benefits of Attending

  • Network with colleagues and thought leaders.
  • Ask world-renowned experts your important questions.
  • Apply state-of-the-art therapies and strategies in your practice.
  • Gain expert perspectives and clarity on areas of clinical uncertainty and controversy.
  • Improve the evidence-based, patient-centered care you provide to your patients.

38th Annual Miami Breast Cancer Conference® 2021 Hot Topics

  • Advances in systemic and locoregional adjuvant and neoadjuvant strategies
  • Impact and potential use of adjuvant CDK4/6 inhibitors in high-risk, early-stage, HR+ breast cancer
  • New options and refinements for immunotherapy in breast cancer
  • Integrating new and emerging treatment approaches for advanced disease into practice
  • Advances in later lines of therapy for HER2+ breast cancer
  • Treatment options in the setting of therapeutic resistance
  • Impact of antibody-drug conjugate therapy in refractory triple-negative breast cancer
  • Locoregional management for de novo metastatic breast cancer
  • Therapeutic sequencing in shifting treatment landscapes
  • State-of-the-art breast cancer imaging
  • Biomarkers to guide prognosis, prediction, and clinical decision making
  • Expert perspectives on breast cancer and COVID-19
  • DCIS management after lumpectomy
  • An update on surgical margin assessment and clinical application
  • Opportunities for de-escalation of therapy
  • Gene profiling: Randomized clinical trial data to guide decision-making in node-positive breast cancer
  • Best practices for treating special populations
  • Axillary management
  • New oral taxane and SERD formulations
  • Management of toxicities associated with new treatment options
  • Targeted axillary dissection versus conventional level 1/2 dissection: Controversies in patient selection
  • Clinical and economic advantages associated with preclinical lymphedema detection and prevention of clinical lymphedema
  • Polygenic risk refines risk assignment for moderate penetrance pathogenic variants (eg, CHEK2, ATM)
  • And much, much more!

Program Chair

Patrick I. Borgen
Patrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Brooklyn, NY


3 Ways to Register

  1. Online: Click here for online registration.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701 (credit card required).
  3. Fax: +1 (609) 257-0705 (credit card required).

Physicians’ Education Resource, LLC (PER®) – MBC21
2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Registration Fees

Mini Symposium* &
Main Conference
March 4 - 7, 2021
Main Conference Only
March 4 - 7, 2021
Advanced Webcast
Week of Virtual
Advanced Webcast
Week of Virtual
Nurses, PAs, Other Health Care Professionals

*Discount does not apply to the mini-symposium or guest registration.
**FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount.
***INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email info@gotoper.com or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested through and including January 25, 2021, and a 50% fee on refunds requested on January 26, 2021, through February 22, 2021. No refunds will be made after February 22, 2021. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians’ Education Resource®, LLC, reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

Meeting information is accurate at the time of posting.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By